Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of homologous recombination deficiency score testing in endometrial Cancer

7 Feb 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Endometrial and Cervical Cancer Treatments
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33563487
DOI: 10.1016/j.ygyno.2020.12.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of homologous recombination deficiency score testing in endometrial CancerPMID 33563487Read ↗

Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in CancerSemantic proximity Read ↗

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancerSemantic proximity Read ↗

Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinomaSemantic proximity Read ↗

Practical guidance for mismatch repair-deficiency testing in endometrial cancerSemantic proximity Read ↗

Expression of DNA repair proteins in endometrial cancer predicts disease outcomeSemantic proximity Read ↗

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug responseSemantic proximity Read ↗

Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and managementSemantic proximity Read ↗

Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay Performance.Semantic proximity Read ↗

Detecting the mutational signature of homologous recombination deficiency in clinical samplesSemantic proximity Read ↗

Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapySemantic proximity Read ↗

Prevalence of homologous recombination deficiency in ovarian, primary peritoneal, and/or fallopian tube cancer: results from HALO-Taiwan subset.Semantic proximity Read ↗

Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.